Thank you, Breca, and good morning, everyone. This is Alex Lopez, Director, Investor Relations. Joining me today from PPG are ...
Thank you, Allison, and thanks, everyone for joining the call today. As we exited 2024, we had a very positive outlook for ...
Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...